购物车
- 全部删除
- 您的购物车当前为空
Piclidenoson (CF-101) 是一种具有口服活性的,选择性的腺苷 A3 受体激动剂。它在不同类型的癌细胞如黑色素瘤、白血病中表现出抗增殖和诱导凋亡的作用,可研究自身免疫性炎症疾病和 COVID-19。
为众多的药物研发团队赋能,
让新药发现更简单!
Piclidenoson (CF-101) 是一种具有口服活性的,选择性的腺苷 A3 受体激动剂。它在不同类型的癌细胞如黑色素瘤、白血病中表现出抗增殖和诱导凋亡的作用,可研究自身免疫性炎症疾病和 COVID-19。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 343 | 现货 | |
2 mg | ¥ 497 | 现货 | |
5 mg | ¥ 997 | 现货 | |
10 mg | ¥ 1,580 | 现货 | |
25 mg | ¥ 3,320 | 现货 | |
50 mg | ¥ 5,320 | 现货 | |
100 mg | ¥ 8,230 | 现货 | |
200 mg | ¥ 10,900 | 现货 | |
500 mg | ¥ 16,500 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 1,090 | 现货 |
产品描述 | Piclidenoson (CF-101), a selective agonist of adenosine A3 receptor(EC50 values of 0.11 μM), induces robust anti-inflammatory effect in psoriasis patients. |
体外活性 | Piclidenoson通过破坏NF-κB信号通路来抑制HaCat细胞的增殖,导致白细胞介素-17和白细胞介素-23的表达水平下降[1]。 |
细胞实验 | [3H]-Thymidine incorporation assay was used to evaluate cell growth.?HaCat cells (2500 cells/well) were incubated with piclidenoson 10?nM and MRS 1523 (50?nM) in 96-well plate for 48 hours.?For the last 24 hours of incubation, each well was pulsed with 1?mCi [3H]-thymidine.?Cells were harvested, and the [3H]-thymidine uptake was determined in an LKB liquid scintillation counter (LKB, Piscataway, NJ, USA).?These experiments were repeated at least 4 times[1]. |
别名 | IB-MECA, CF-101 |
分子量 | 510.29 |
分子式 | C18H19IN6O4 |
CAS No. | 152918-18-8 |
Smiles | CNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(NCc3cccc(I)c3)ncnc12 |
密度 | 1.98g/cm3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 60 mg/mL (117.58 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容